Hims & Hers Health is trading 5.11% up now at €27.58, with no clear company-specific catalyst identified for the August 26, 2026 move.
- Recent volatility followed reports that Visa placed the company in a monitoring program after July chargebacks linked to its weight-loss subscriptions, including an $8 fee per dispute.
- Visa’s expected September bill is nearly $75,000.
- Broader indices were flat, so market-wide momentum does not clearly explain the rebound.